Berberine in the treatment of ulcerative colitis: A possible pathway through Tuft cells
Ulcerative colitis (UC) is an inflammatory bowel disease with complex pathogenesis, which is affected by genetic factors, intestinal immune status and intestinal microbial homeostasis. Intestinal epithelial barrier defect is crucial to the development of UC. Berberine, extracted from Chinese medicin...
Main Authors: | Xinyu Xiong, Zhe Cheng, Fan Wu, Meilin Hu, Zhimin Liu, Ruolan Dong, Guang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332220313226 |
Similar Items
-
Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis
by: Deng J, et al.
Published: (2020-06-01) -
Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon
by: Huantian Cui, et al.
Published: (2018-05-01) -
Berberine Protects Mice Against Dextran Sulfate Sodium-Induced Colitis by Activating mTORC1 Pathway
by: Qingjun Li, et al.
Published: (2019-07-01) -
Berberine Suppresses Colonic Inflammation in Dextran Sulfate Sodium–Induced Murine Colitis Through Inhibition of Cytosolic Phospholipase A2 Activity
by: Lixiang Zhai, et al.
Published: (2020-11-01) -
Role of colonic microbiota in the pathogenesis of ulcerative colitis
by: Ling-yan Pei, et al.
Published: (2019-01-01)